期刊文献+

肿瘤坏死因子α-308G/A多态性与类风湿关节炎疾病及肿瘤坏死因子α抑制剂疗效的相关性研究进展 被引量:6

原文传递
导出
摘要 类风湿关节炎(RA)是一种慢性、系统性炎症疾病,患病率约为1%,患者多数为女性,其疾病发展进程为慢性滑膜炎、进行性关节损伤直至最后丧失运动能力。肿瘤坏死因子(TNF)-α作为促炎细胞因子在RA发病过程中的作用逐渐被人们重视。有研究提示,TNF-α基因多态性与RA的疾病进展及TNF-α抑制剂的疗效具有相关性,其中研究最深入的是TNF-α-308单核苷酸多态性(SNP),我们对该SNP的研究进展进行概述。
出处 《临床内科杂志》 CAS 2015年第8期570-572,共3页 Journal of Clinical Internal Medicine
  • 相关文献

参考文献30

  • 1Harris Jr ED.Rheumatoid arthritis ;pathophysiology and implications for therapy[J].N Engl J Med,1990,322(18):1277-1289.
  • 2陈程(综述),楼觉人(审校).TNFα在类风湿关节炎中的作用及抗TNFα药物的进展[J].国际生物制品学杂志,2010(1):38-43. 被引量:3
  • 3王贤才.西氏内科学(下册)[M].西安:世界图书出版公司,2009.2507-2510.
  • 4Smolen JS,Landew6 R,Breedveld FC,et al.EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs:2013 update[J].Ann Rheum Dis,2014,73(3):492-509.
  • 5刘毅,郭珍,陈卿,王素萍.中国人群TNF-α-308基因多态性与慢性HBV感染关联性的Meta分析[J].中华流行病学杂志,2014,35(3):312-316. 被引量:3
  • 6Perricone C,Ceccarelli F,Valesini G.An overview on the genetic of rheumatoid arthritis:a never-ending story[J].Autoimmun Rev,2011,10(10):599-608.
  • 7Khanna D,Wu H,Park G,et al.Association of tumor necrosis factor a polymorphism,but not the shared epitope,with increased radiographic progression in a seropositive rheumatoid arthritis inception cohort[J].Arthritis Rheum,2006,54(4):1105-1116.
  • 8Aranda F,Peres Wingeyer SD,Schneeberger E,et al.The-308 G/A pol- ymorphism in the tumor necrosis factor-a gene is not associated with development and progression of rheumatoid arthritis in Argentinean pa- tients[J].Int J Rheum Dis,2014.[Epub ahead of print].
  • 9Song GG,Bae SC,Kim JH,et al.Association between TNF-α promoter-308 A/G polymorphism and rheumatoid arthritis;a meta-analysis[J].Rheumatol Int,2014,34(4):465471.
  • 10刘霞,王国春.生物制剂在类风湿关节炎的应用进展[J].临床内科杂志,2013,30(10):656-658. 被引量:5

二级参考文献89

共引文献9

同被引文献102

  • 1Ma X,Xu S. TNF inhibitor therapy for rheumatoid arthritis [ J].Biomed Rep, 2013, 1(2) : 177-184.
  • 2Rosenblum H, Amital H. Anti-TNF therapy : safety aspects of tak-ing the risk[ J]. Autoimmun rev, 2011, 10(9) : 563-568.
  • 3Dommasch ED, Abuabara K, Shin DB, et al. The risk of infectionand malignancy with tumor necrosis factor antagonists in adults withpsoriatic disease : a systematic review and meta-analysis of random-ized controlled trials [ J ] . J Am Acad Dermatol,2011 , 64 ( 6 ):1035-1050.
  • 4Jadad AR, Moore RA, Carroll D, et al. Assessing the quality ofreports of randomized clinical trials: is blinding necessary? [ J].Control Clin Trials, 1996,17(1): 1-12.
  • 5Sweeting MJ, Sutton AJ, Lambert PC. What to add to nothing? useand avoidance of continuity corrections in meta-analysis of sparsedata[J]. Stat Med, 2004,23(9) : 1351-1375.
  • 6Asahina A, Nakagawa H, Etoh T, et al. Adalimumab in Japanesepatients with moderate to severe chronic plaque psoriasis : efficacyand safety results from a Phase II/III randomized controlled study[J]. J Dermatol, 2010,37(4) : 299-310.
  • 7van der Heijde D, Kivitz A, Schiff MH, et al. Efficacy and safetyof adalimumab in patients with ankylosing spondylitis : Results of amulticenter, randomized, double-blind, placebo-controlled trial[J]. Arthritis Rheum, 2006,54(7) : 2136-2146.
  • 8Furst DE, Schiff MH, Fleischmann RM, et al. Adalimumab, afully human anti tumor necrosis factor-alpha monoclonal antibody,and concomitant standard antirheumatic therapy for the treatment ofrheumatoid arthritis : results of STAR (Safety Trial of Adalimumabin Rheumatoid Arthritis) [J]. J Rheumatol, 2003,30(12):2563-2571.
  • 9Saurat JH,Stingl G,Dubertret L,et al. Efficacy and safety resultsfrom the randomized controlled comparative study of adalimumabvs. methotrexate vs, placebo in patients with psoriasis ( CHAMPI-ON) [J]. Br J Dermatol, 2008,158(3) : 558-566.
  • 10Gordon KB, Langley RG, Leonardi C,et al. Clinical response toadalimumab treatment in patients with moderate to severe psoriasis :double-blind, randomized controlled trial and open-label extensionstudy[ J]. J Am Acad of Dermatol, 2006, 55(4) : 598-606.

引证文献6

二级引证文献66

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部